Analysts’ Price Target Changes for November 13th (AADX, ACAD, AGL, AIN, AJG, ALM, ALMS, AMAT, ANDG, AON)

Analysts’ price target changes for Friday, November 13th:

Applied Aerospace & Defense (NYSE:AADX) had its price target cut by Guggenheim from $30.00 to $15.00. Guggenheim currently has a buy rating on the stock.

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its target price cut by Morgan Stanley from $28.00 to $24.00. The firm currently has an equal weight rating on the stock.

Agilon Health (NYSE:AGL) had its target price raised by Wells Fargo & Company from $146.00 to $170.00. Wells Fargo & Company currently has an overweight rating on the stock.

Albany International (NYSE:AIN) had its target price boosted by Truist Financial from $61.00 to $71.00. They currently have a hold rating on the stock.

Arthur J. Gallagher & Co. (NYSE:AJG) had its price target boosted by Mizuho from $302.00 to $307.00. They currently have an outperform rating on the stock.

Almonty Industries (NASDAQ:ALM) had its target price trimmed by Stifel Nicolaus from $21.00 to $18.00. They currently have a buy rating on the stock.

Alumis (NASDAQ:ALMS) had its price target trimmed by HC Wainwright from $15.00 to $9.00. HC Wainwright currently has a buy rating on the stock.

Alumis (NASDAQ:ALMS) had its price target lowered by Wells Fargo & Company from $25.00 to $18.00. Wells Fargo & Company currently has an overweight rating on the stock.

Applied Materials (NASDAQ:AMAT) had its target price trimmed by Jefferies Financial Group from $770.00 to $580.00. The firm currently has a buy rating on the stock.

Applied Materials (NASDAQ:AMAT) had its price target lowered by TD Cowen from $700.00 to $500.00. TD Cowen currently has a buy rating on the stock.

Applied Materials (NASDAQ:AMAT) had its price target reduced by Needham & Company LLC from $580.00 to $470.00. The firm currently has a buy rating on the stock.

Applied Materials (NASDAQ:AMAT) had its price target cut by Stifel Nicolaus from $650.00 to $600.00. Stifel Nicolaus currently has a buy rating on the stock.

Applied Materials (NASDAQ:AMAT) had its price target lowered by Sanford C. Bernstein from $700.00 to $600.00. They currently have an outperform rating on the stock.

Applied Materials (NASDAQ:AMAT) had its price target lowered by Bank of America from $650.00 to $520.00. Bank of America currently has a buy rating on the stock.

Applied Materials (NASDAQ:AMAT) had its price target lowered by Wells Fargo & Company from $610.00 to $500.00. The firm currently has an overweight rating on the stock.

Andersen Group (NYSE:ANDG) had its price target increased by Wells Fargo & Company from $49.00 to $61.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Andersen Group (NYSE:ANDG) had its target price increased by Robert W. Baird from $64.00 to $71.00. The firm currently has an outperform rating on the stock.

AON (NYSE:AON) had its price target increased by Mizuho from $363.00 to $373.00. They currently have an outperform rating on the stock.

APA (NASDAQ:APA) had its target price raised by Barclays from $44.00 to $48.00. Barclays currently has an equal weight rating on the stock.

Ardent Health (NYSE:ARDT) had its price target boosted by Bank of America from $12.00 to $14.00. The firm currently has an underperform rating on the stock.

argenex (NASDAQ:ARGX) had its target price reduced by Morgan Stanley from $1,190.00 to $1,130.00. The firm currently has an overweight rating on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its target price trimmed by Stifel Nicolaus from $104.00 to $96.00. Stifel Nicolaus currently has a buy rating on the stock.

Ascendis Pharma A/S (NASDAQ:ASND) had its target price cut by HC Wainwright from $344.00 to $335.00. HC Wainwright currently has a buy rating on the stock.

Ascendis Pharma A/S (NASDAQ:ASND) had its price target raised by Cantor Fitzgerald from $300.00 to $315.00. They currently have an overweight rating on the stock.

Ascendis Pharma A/S (NASDAQ:ASND) had its target price boosted by Canaccord Genuity Group from $268.00 to $274.00. The firm currently has a hold rating on the stock.

Ascendis Pharma A/S (NASDAQ:ASND) had its target price raised by TD Cowen from $341.00 to $352.00. They currently have a buy rating on the stock.

Ascendis Pharma A/S (NASDAQ:ASND) had its price target increased by UBS Group from $269.00 to $315.00. UBS Group currently has a buy rating on the stock.

Alphatec (NASDAQ:ATEC) had its target price trimmed by HC Wainwright from $24.00 to $20.00. They currently have a buy rating on the stock.

ATI (NYSE:ATI) had its target price boosted by BTIG Research from $250.00 to $260.00. BTIG Research currently has a buy rating on the stock.

Atalaya Mining (LON:ATYM) had its target price increased by Berenberg Bank from GBX 1,260 to GBX 1,300. The firm currently has a buy rating on the stock.

Anteris Technologies Global (NASDAQ:AVR) had its target price reduced by Barclays from $10.00 to $9.00. Barclays currently has an equal weight rating on the stock.

Avnet (NASDAQ:AVT) had its price target reduced by Bank of America from $115.00 to $110.00. They currently have a neutral rating on the stock.

Axsome Therapeutics (NASDAQ:AXSM) had its price target cut by Morgan Stanley from $249.00 to $223.00. Morgan Stanley currently has an equal weight rating on the stock.

Brookfield Asset Management (NYSE:BAM) (TSE:BAM.A) had its price target boosted by Wells Fargo & Company from $51.00 to $57.00. Wells Fargo & Company currently has an overweight rating on the stock.

BridgeBio Pharma (NASDAQ:BBIO) had its target price increased by Morgan Stanley from $88.00 to $91.00. The firm currently has an overweight rating on the stock.

Bath & Body Works (NYSE:BBWI) had its target price raised by UBS Group from $17.00 to $22.00. UBS Group currently has a neutral rating on the stock.

BJ’s Wholesale Club (NYSE:BJ) had its price target raised by Wells Fargo & Company from $110.00 to $120.00. Wells Fargo & Company currently has an overweight rating on the stock.

BKV (NYSE:BKV) had its price target lowered by Barclays from $36.00 to $33.00. The firm currently has an overweight rating on the stock.

BitMine Immersion Technologies (NYSE:BMNR) had its price target trimmed by B. Riley Financial from $34.00 to $27.00. They currently have a buy rating on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target cut by Morgan Stanley from $119.00 to $103.00. The firm currently has an overweight rating on the stock.

Brookfield (NYSE:BN) had its target price cut by Royal Bank Of Canada from $61.00 to $59.00. The firm currently has an outperform rating on the stock.

Broadstone Net Lease (NYSE:BNL) had its target price raised by Truist Financial from $21.00 to $22.00. They currently have a buy rating on the stock.

Brown & Brown (NYSE:BRO) had its price target raised by Mizuho from $81.00 to $84.00. They currently have an outperform rating on the stock.

BSR Real Estate Investment Trust (NYSE:BSRT) had its target price lowered by Royal Bank Of Canada from $12.50 to $11.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Burlington Stores (NYSE:BURL) had its price target trimmed by Wells Fargo & Company from $370.00 to $330.00. Wells Fargo & Company currently has an overweight rating on the stock.

Broadwind Energy (NASDAQ:BWEN) had its target price reduced by Roth Capital from $6.50 to $5.00. The firm currently has a buy rating on the stock.

BXP (NYSE:BXP) had its target price lowered by UBS Group from $70.00 to $66.00. The firm currently has a neutral rating on the stock.

KANZHUN (NASDAQ:BZ) had its target price cut by Barclays from $20.00 to $17.00. Barclays currently has an overweight rating on the stock.

Candel Therapeutics (NASDAQ:CADL) had its price target cut by Canaccord Genuity Group from $25.00 to $13.00. They currently have a buy rating on the stock.

Candel Therapeutics (NASDAQ:CADL) had its price target lowered by Stifel Nicolaus from $22.00 to $19.00. Stifel Nicolaus currently has a buy rating on the stock.

Crescent Biopharma (NASDAQ:CBIO) had its price target boosted by HC Wainwright from $36.00 to $40.00. HC Wainwright currently has a buy rating on the stock.

Crescent Biopharma (NASDAQ:CBIO) had its price target cut by Piper Sandler from $35.00 to $32.00. Piper Sandler currently has an overweight rating on the stock.

Cerebras Systems (NASDAQ:CBRS) had its target price lowered by UBS Group from $250.00 to $155.00. UBS Group currently has a buy rating on the stock.

Cerebras Systems (NASDAQ:CBRS) had its price target cut by Needham & Company LLC from $300.00 to $200.00. Needham & Company LLC currently has a buy rating on the stock.

Cardinal Infrastructure Group (NASDAQ:CDNL) had its price target reduced by Truist Financial from $30.00 to $10.00. The firm currently has a buy rating on the stock.

Cigna Group (NYSE:CI) had its price target raised by Wells Fargo & Company from $307.00 to $325.00. They currently have an equal weight rating on the stock.

Chimera Investment (NYSE:CIM) had its target price reduced by Royal Bank Of Canada from $13.00 to $7.00. They currently have a sector perform rating on the stock.

Commercial Metals (NYSE:CMC) had its price target raised by Barclays from $72.00 to $77.00. The firm currently has an equal weight rating on the stock.

CNX Resources (NYSE:CNX) had its target price raised by Barclays from $35.00 to $36.00. The firm currently has an underweight rating on the stock.

Concentra Group Holdings Parent (NYSE:CON) had its target price increased by Wells Fargo & Company from $40.00 to $48.00. Wells Fargo & Company currently has an overweight rating on the stock.

ConocoPhillips (NYSE:COP) had its price target boosted by Barclays from $150.00 to $165.00. Barclays currently has an overweight rating on the stock.

California Resources (NYSE:CRC) had its price target trimmed by Barclays from $74.00 to $68.00. Barclays currently has an overweight rating on the stock.

Cisco Systems (NASDAQ:CSCO) had its price target reduced by Truist Financial from $140.00 to $127.00. Truist Financial currently has a buy rating on the stock.

Cisco Systems (NASDAQ:CSCO) had its price target trimmed by Barclays from $123.00 to $109.00. Barclays currently has an equal weight rating on the stock.

Cisco Systems (NASDAQ:CSCO) had its price target trimmed by Rosenblatt Securities from $165.00 to $140.00. The firm currently has a buy rating on the stock.

Cisco Systems (NASDAQ:CSCO) had its target price cut by Wells Fargo & Company from $150.00 to $130.00. They currently have an overweight rating on the stock.

Corteva (NYSE:CTVA) had its target price reduced by UBS Group from $15.00 to $10.00. UBS Group currently has a neutral rating on the stock.

Corteva (NYSE:CTVA) had its price target lowered by Royal Bank Of Canada from $17.00 to $11.00. The firm currently has an outperform rating on the stock.

Chevron (NYSE:CVX) had its target price boosted by Barclays from $244.00 to $248.00. They currently have an equal weight rating on the stock.

Clearway Energy (NYSE:CWEN) had its target price increased by Truist Financial from $40.00 to $42.00. The firm currently has a buy rating on the stock.

Delek US (NYSE:DK) had its target price reduced by Mizuho from $83.00 to $80.00. The firm currently has a neutral rating on the stock.

DICK’S Sporting Goods (NYSE:DKS) had its target price boosted by Wells Fargo & Company from $185.00 to $195.00. The firm currently has an overweight rating on the stock.

Denali Therapeutics (NASDAQ:DNLI) had its price target trimmed by Morgan Stanley from $42.00 to $37.00. They currently have an overweight rating on the stock.

DarioHealth (NASDAQ:DRIO) had its price target cut by Stifel Nicolaus to $5.00. The firm currently has a buy rating on the stock.

Devon Energy (NYSE:DVN) had its price target raised by Barclays from $57.00 to $59.00. The firm currently has an overweight rating on the stock.

Okeanis Eco Tankers (NYSE:ECO) had its target price increased by B. Riley Financial from $100.00 to $120.00. They currently have a buy rating on the stock.

Eagle Financial Services (NASDAQ:EFSI) had its price target increased by Freedom Broker from $43.00 to $46.20. Freedom Broker currently has a hold rating on the stock.

Enlight Renewable Energy (NASDAQ:ENLT) had its target price cut by Truist Financial from $104.00 to $102.00. Truist Financial currently has a buy rating on the stock.

Enersys (NYSE:ENS) had its price target lowered by Oppenheimer from $250.00 to $210.00. The firm currently has an outperform rating on the stock.

EOG Resources (NYSE:EOG) had its target price increased by Barclays from $155.00 to $168.00. Barclays currently has an equal weight rating on the stock.

Edgewell Personal Care (NYSE:EPC) had its target price boosted by Wells Fargo & Company from $30.00 to $32.00. The firm currently has an overweight rating on the stock.

ERock (NYSE:EROC) had its price target trimmed by Barclays from $23.00 to $22.00. They currently have an overweight rating on the stock.

enCore Energy (NASDAQ:EU) had its target price reduced by HC Wainwright to $1.50. The firm currently has a buy rating on the stock.

Evommune (NYSE:EVMN) had its price target cut by Needham & Company LLC from $28.00 to $25.00. They currently have a buy rating on the stock.

Exelixis (NASDAQ:EXEL) had its price target lowered by Morgan Stanley from $60.00 to $57.00. The firm currently has an equal weight rating on the stock.

National Vision (NASDAQ:EYE) had its target price lowered by UBS Group from $34.00 to $31.00. They currently have a buy rating on the stock.

National Vision (NASDAQ:EYE) had its price target reduced by Barclays from $27.00 to $24.00. Barclays currently has an overweight rating on the stock.

EZCORP (NASDAQ:EZPW) had its price target cut by Canaccord Genuity Group from $45.00 to $44.00. They currently have a buy rating on the stock.

Diamondback Energy (NASDAQ:FANG) had its target price increased by Barclays from $221.00 to $223.00. They currently have an overweight rating on the stock.

Figure Technology Solutions (NASDAQ:FIGR) had its price target lowered by Needham & Company LLC from $55.00 to $50.00. Needham & Company LLC currently has a buy rating on the stock.

Forgent Power Solutions (NYSE:FPS) had its price target reduced by Robert W. Baird from $55.00 to $38.00. They currently have an outperform rating on the stock.

Forgent Power Solutions (NYSE:FPS) had its price target cut by Sanford C. Bernstein from $48.00 to $33.00. They currently have an outperform rating on the stock.

Forgent Power Solutions (NYSE:FPS) had its target price reduced by KeyCorp from $60.00 to $46.00. They currently have an overweight rating on the stock.

Forgent Power Solutions (NYSE:FPS) had its target price cut by Oppenheimer from $60.00 to $40.00. Oppenheimer currently has an outperform rating on the stock.

Forgent Power Solutions (NYSE:FPS) had its price target lowered by TD Cowen from $76.00 to $55.00. TD Cowen currently has a buy rating on the stock.

fuboTV (NYSE:FUBO) had its target price trimmed by B. Riley Financial from $18.00 to $16.00. They currently have a buy rating on the stock.

GAP (NYSE:GAP) had its price target trimmed by Wells Fargo & Company from $23.00 to $22.00. They currently have an equal weight rating on the stock.

Genmab A/S (NASDAQ:GMAB) had its target price reduced by Morgan Stanley from $57.00 to $56.00. The firm currently has an equal weight rating on the stock.

HawkEye 360 (NYSE:HAWK) had its target price raised by Piper Sandler from $22.00 to $24.00. The firm currently has an overweight rating on the stock.

Robinhood Markets (NASDAQ:HOOD) had its target price cut by The Goldman Sachs Group from $128.00 to $115.00. The firm currently has a buy rating on the stock.

Heartflow (NASDAQ:HTFL) had its target price boosted by Robert W. Baird from $56.00 to $68.00. The firm currently has an outperform rating on the stock.

Heartflow (NASDAQ:HTFL) had its price target boosted by Canaccord Genuity Group from $56.00 to $69.00. The firm currently has a buy rating on the stock.

Heartflow (NASDAQ:HTFL) had its target price increased by Stifel Nicolaus from $45.00 to $70.00. The firm currently has a buy rating on the stock.

Heartflow (NASDAQ:HTFL) had its target price increased by Wells Fargo & Company from $39.00 to $70.00. Wells Fargo & Company currently has an overweight rating on the stock.

Immunocore (NASDAQ:IMCR) had its price target reduced by Morgan Stanley from $43.00 to $42.00. Morgan Stanley currently has an equal weight rating on the stock.

ITG (NASDAQ:ITG) had its target price cut by Stifel Nicolaus from $9.00 to $8.00. Stifel Nicolaus currently has a buy rating on the stock.

Integra Resources (NYSEAMERICAN:ITRG) had its price target lowered by Roth Capital from $5.00 to $3.75. Roth Capital currently has a buy rating on the stock.

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its target price raised by Morgan Stanley from $319.00 to $324.00. They currently have an overweight rating on the stock.

Kodiak Gas Services (NYSE:KGS) had its target price reduced by Wells Fargo & Company from $93.00 to $66.00. They currently have an overweight rating on the stock.

KinderCare Learning Companies (NYSE:KLC) had its target price trimmed by The Goldman Sachs Group from $3.90 to $3.40. The firm currently has a neutral rating on the stock.

Kodiak Sciences (NASDAQ:KOD) had its target price boosted by UBS Group from $120.00 to $150.00. The firm currently has a buy rating on the stock.

Pasithea Therapeutics (NASDAQ:KTTA) had its target price boosted by HC Wainwright from $3.00 to $4.00. HC Wainwright currently has a buy rating on the stock.

LifeMD (NASDAQ:LFMD) had its target price cut by Mizuho from $7.00 to $6.00. The firm currently has an outperform rating on the stock.

Liftoff Mobile (NASDAQ:LFTO) had its target price raised by Wells Fargo & Company from $21.00 to $27.00. The firm currently has an overweight rating on the stock.

Liftoff Mobile (NASDAQ:LFTO) had its price target increased by Piper Sandler from $19.00 to $24.00. The firm currently has a neutral rating on the stock.

Liftoff Mobile (NASDAQ:LFTO) had its target price raised by Royal Bank Of Canada from $35.00 to $38.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Liftoff Mobile (NASDAQ:LFTO) had its price target cut by Barclays from $34.00 to $30.00. They currently have an overweight rating on the stock.

Liftoff Mobile (NASDAQ:LFTO) had its price target raised by BTIG Research from $27.00 to $31.00. BTIG Research currently has a buy rating on the stock.

LGN (NASDAQ:LGN) had its target price trimmed by BTIG Research from $100.00 to $60.00. They currently have a buy rating on the stock.

Lineage (NASDAQ:LINE) had its price target raised by Piper Sandler from $36.00 to $37.00. They currently have a neutral rating on the stock.

Intuitive Machines (NASDAQ:LUNR) had its price target cut by Roth Capital from $30.00 to $20.00. The firm currently has a buy rating on the stock.

Lyell Immunopharma (NASDAQ:LYEL) had its target price trimmed by HC Wainwright from $45.00 to $39.00. They currently have a buy rating on the stock.

Mobility Global (NYSE:MBGL) had its price target increased by Barclays from $23.00 to $25.00. Barclays currently has an equal weight rating on the stock.

Mobility Global (NYSE:MBGL) had its price target increased by Royal Bank Of Canada from $23.00 to $25.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Mobility Global (NYSE:MBGL) had its price target increased by Wells Fargo & Company from $23.00 to $29.00. The firm currently has an overweight rating on the stock.

Mobility Global (NYSE:MBGL) had its price target boosted by Robert W. Baird from $22.00 to $26.00. The firm currently has a neutral rating on the stock.

MiniMed Group (NASDAQ:MMED) had its target price cut by Barclays from $22.00 to $20.00. They currently have an equal weight rating on the stock.

Marathon Petroleum (NYSE:MPC) had its price target cut by Mizuho from $457.00 to $440.00. Mizuho currently has a neutral rating on the stock.

Merlin, Inc. Common Stock (NASDAQ:MRLN) had its price target lowered by Roth Capital to $4.00. Roth Capital currently has a buy rating on the stock.

Marsh & McLennan Companies (NYSE:MRSH) had its target price increased by Mizuho from $200.00 to $218.00. The firm currently has a neutral rating on the stock.

Murphy Oil (NYSE:MUR) had its price target raised by Barclays from $34.00 to $35.00. They currently have an underweight rating on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its target price increased by Morgan Stanley from $185.00 to $191.00. They currently have an equal weight rating on the stock.

Nexxen International (NASDAQ:NEXN) had its target price raised by Royal Bank Of Canada from $13.00 to $14.00. The firm currently has an outperform rating on the stock.

NIQ Global Intelligence (NYSE:NIQ) had its target price increased by Royal Bank Of Canada from $17.00 to $23.00. Royal Bank Of Canada currently has an outperform rating on the stock.

NIQ Global Intelligence (NYSE:NIQ) had its target price raised by Barclays from $24.00 to $25.00. They currently have an overweight rating on the stock.

NIQ Global Intelligence (NYSE:NIQ) had its price target raised by Needham & Company LLC from $21.00 to $24.00. They currently have a buy rating on the stock.

NIQ Global Intelligence (NYSE:NIQ) had its target price increased by Wells Fargo & Company from $16.50 to $22.00. The firm currently has an overweight rating on the stock.

Neptune Insurance (NYSE:NP) had its target price trimmed by Mizuho from $33.00 to $31.00. Mizuho currently has a neutral rating on the stock.

NeuroPace (NASDAQ:NPCE) had its price target reduced by KeyCorp from $18.00 to $14.00. They currently have an overweight rating on the stock.

New Era Energy & Digital (NASDAQ:NUAI) had its target price raised by Roth Capital from $7.00 to $17.00. They currently have a buy rating on the stock.

NVIDIA (NASDAQ:NVDA) had its price target reduced by Barclays from $275.00 to $210.00. They currently have an overweight rating on the stock.

Orchestra BioMed (NASDAQ:OBIO) had its target price raised by BTIG Research from $10.00 to $12.00. They currently have a buy rating on the stock.

Orchestra BioMed (NASDAQ:OBIO) had its target price boosted by HC Wainwright from $10.00 to $12.00. The firm currently has a buy rating on the stock.

Once Upon A Farm (NYSE:OFRM) had its price target cut by TD Cowen from $13.00 to $10.00. They currently have a hold rating on the stock.

Oklo (NYSE:OKLO) had its target price lowered by Truist Financial from $31.00 to $28.00. They currently have a hold rating on the stock.

BeOne Medicines (NASDAQ:ONC) had its target price raised by Morgan Stanley from $465.00 to $476.00. The firm currently has an overweight rating on the stock.

Ondas (NASDAQ:ONDS) had its target price reduced by Needham & Company LLC from $19.00 to $14.00. They currently have a buy rating on the stock.

Ovintiv (NYSE:OVV) had its price target increased by Barclays from $80.00 to $85.00. The firm currently has an overweight rating on the stock.

Occidental Petroleum (NYSE:OXY) had its price target increased by Barclays from $71.00 to $73.00. The firm currently has an overweight rating on the stock.

Proficient Auto Logistics (NASDAQ:PAL) had its price target trimmed by Stifel Nicolaus from $10.00 to $9.00. Stifel Nicolaus currently has a buy rating on the stock.

Par Pacific (NYSE:PARR) had its price target reduced by Mizuho from $91.00 to $80.00. They currently have a neutral rating on the stock.

PepGen (NASDAQ:PEPG) had its target price boosted by Guggenheim from $7.00 to $15.00. They currently have a buy rating on the stock.

Fidelis Insurance (NYSE:PLGO) had its target price raised by Keefe, Bruyette & Woods from $28.00 to $32.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.

Paysafe (NYSE:PSFE) had its target price trimmed by UBS Group from $7.00 to $3.50. UBS Group currently has a sell rating on the stock.

Paysafe (NYSE:PSFE) had its price target cut by Royal Bank Of Canada from $9.00 to $6.00. The firm currently has a sector perform rating on the stock.

Persimmon (LON:PSN) had its price target boosted by Berenberg Bank from GBX 1,150 to GBX 1,240. They currently have a hold rating on the stock.

Qiagen (NYSE:QGEN) had its price target boosted by UBS Group from $48.00 to $50.00. They currently have a neutral rating on the stock.

QXO (NYSE:QXO) had its target price reduced by KeyCorp from $28.00 to $19.00. They currently have an overweight rating on the stock.

Ross Stores (NASDAQ:ROST) had its price target cut by Wells Fargo & Company from $248.00 to $242.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Range Resources (NYSE:RRC) had its price target increased by Barclays from $42.00 to $67.00. The firm currently has an equal weight rating on the stock.

Riskified (NYSE:RSKD) had its price target increased by The Goldman Sachs Group from $7.50 to $9.00. They currently have a sell rating on the stock.

Sunrun (NASDAQ:RUN) had its target price trimmed by Wells Fargo & Company from $17.00 to $14.00. Wells Fargo & Company currently has an overweight rating on the stock.

Revolution Medicines (NASDAQ:RVMD) had its price target trimmed by Morgan Stanley from $272.00 to $247.00. The firm currently has an overweight rating on the stock.

Ryan Specialty (NYSE:RYAN) had its price target increased by Mizuho from $40.00 to $48.00. Mizuho currently has a neutral rating on the stock.

Sally Beauty (NYSE:SBH) had its price target boosted by TD Cowen from $19.00 to $22.00. They currently have a buy rating on the stock.

Sagimet Biosciences (NASDAQ:SGMT) had its price target reduced by Canaccord Genuity Group from $56.00 to $50.00. Canaccord Genuity Group currently has a buy rating on the stock.

Spyglass Pharma (NASDAQ:SGP) had its target price raised by Stifel Nicolaus from $42.00 to $44.00. The firm currently has a buy rating on the stock.

Spectrum Brands (NYSE:SPB) had its target price lowered by Canaccord Genuity Group from $110.00 to $105.00. Canaccord Genuity Group currently has a buy rating on the stock.

Spire Global (NYSE:SPIR) had its price target trimmed by Canaccord Genuity Group from $22.50 to $21.50. Canaccord Genuity Group currently has a buy rating on the stock.

Sound Point Meridian Capital (NYSE:SPMC) had its target price reduced by B. Riley Financial from $10.00 to $6.50. The firm currently has a neutral rating on the stock.

Sutro Biopharma (NASDAQ:STRO) had its target price increased by Barclays from $56.00 to $57.00. The firm currently has an overweight rating on the stock.

STUB (NYSE:STUB) had its target price cut by TD Cowen from $12.00 to $10.00. TD Cowen currently has a buy rating on the stock.

Tecnoglass (NYSE:TGLS) had its target price raised by B. Riley Financial from $55.00 to $63.00. B. Riley Financial currently has a buy rating on the stock.

TIM (NYSE:TIMB) had its target price raised by Barclays from $20.00 to $22.00. The firm currently has an equal weight rating on the stock.

TJX Companies (NYSE:TJX) had its target price trimmed by Wells Fargo & Company from $140.00 to $135.00. The firm currently has an equal weight rating on the stock.

TMC the metals (NASDAQ:TMC) had its target price trimmed by HC Wainwright from $11.75 to $5.50. HC Wainwright currently has a buy rating on the stock.

Tenaris (NYSE:TS) had its price target increased by Stifel Nicolaus from $57.00 to $67.00. Stifel Nicolaus currently has a buy rating on the stock.

Tetra Tech (NASDAQ:TTEK) had its price target increased by KeyCorp from $41.00 to $42.00. The firm currently has an overweight rating on the stock.

Twist Bioscience (NASDAQ:TWST) had its target price lowered by Robert W. Baird from $187.00 to $135.00. The firm currently has an outperform rating on the stock.

Twist Bioscience (NASDAQ:TWST) had its price target cut by TD Cowen from $190.00 to $137.00. The firm currently has a buy rating on the stock.

United States Antimony (NYSE:UAMY) had its target price reduced by HC Wainwright from $9.25 to $6.50. HC Wainwright currently has a buy rating on the stock.

Visteon (NASDAQ:VC) had its target price boosted by Royal Bank Of Canada from $100.00 to $102.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Vylor (NYSE:VYLR) had its target price reduced by UBS Group from $89.00 to $87.00. UBS Group currently has a buy rating on the stock.

Warner Music Group (NASDAQ:WMG) had its price target raised by Morgan Stanley from $36.00 to $39.00. They currently have an overweight rating on the stock.

Walmart (NASDAQ:WMT) had its price target increased by Wells Fargo & Company from $120.00 to $135.00. They currently have an overweight rating on the stock.

Wise Group (NASDAQ:WSE) had its price target increased by UBS Group from $17.25 to $18.00. They currently have a buy rating on the stock.

Willis Towers Watson Public (NASDAQ:WTW) had its price target raised by Mizuho from $370.00 to $384.00. They currently have an outperform rating on the stock.

Westwater Resources (NASDAQ:WWR) had its target price cut by HC Wainwright from $1.50 to $1.25. They currently have a buy rating on the stock.

Wolverine World Wide (NYSE:WWW) had its target price increased by Robert W. Baird from $26.00 to $27.00. They currently have an outperform rating on the stock.

Wolverine World Wide (NYSE:WWW) had its price target boosted by Stifel Nicolaus from $26.00 to $28.00. Stifel Nicolaus currently has a buy rating on the stock.

Wolverine World Wide (NYSE:WWW) had its target price boosted by KeyCorp from $25.00 to $27.00. The firm currently has an overweight rating on the stock.

X-Energy (NASDAQ:XE) had its target price reduced by TD Cowen from $35.00 to $25.00. They currently have a buy rating on the stock.

ExxonMobil (NYSE:XOM) had its price target raised by Barclays from $200.00 to $206.00. They currently have an overweight rating on the stock.

YETI (NYSE:YETI) had its target price cut by Canaccord Genuity Group from $46.00 to $42.00. The firm currently has a hold rating on the stock.

YETI (NYSE:YETI) had its price target trimmed by KeyCorp from $57.00 to $49.00. They currently have an overweight rating on the stock.

YETI (NYSE:YETI) had its target price reduced by Robert W. Baird from $57.00 to $50.00. They currently have an outperform rating on the stock.

YETI (NYSE:YETI) had its target price lowered by Stifel Nicolaus from $50.00 to $48.00. Stifel Nicolaus currently has a buy rating on the stock.

York Space Systems (NYSE:YSS) had its target price cut by Piper Sandler from $8.00 to $7.00. They currently have a neutral rating on the stock.

York Space Systems (NYSE:YSS) had its target price lowered by Needham & Company LLC from $18.00 to $10.00. Needham & Company LLC currently has a buy rating on the stock.

Zeta Global (NYSE:ZETA) had its target price boosted by Freedom Broker from $29.00 to $33.00. The firm currently has a hold rating on the stock.

Zevra Therapeutics (NASDAQ:ZVRA) had its price target trimmed by Cantor Fitzgerald from $25.00 to $19.00. They currently have an overweight rating on the stock.

Zymeworks (NASDAQ:ZYME) had its target price increased by Citizens Jmp from $32.00 to $39.00. The firm currently has a market outperform rating on the stock.